Shopping Cart

IBX Secures Additional Capital — Shareholders Exercise Options

IBX Secures Additional Capital — Shareholders Exercise Options

Imagion Biosystems announced that it has received a total of $143,157 for the exercise of options.

Composed of $142,200 for 2,370,000 options exercisable at 6 cents and expiring on 27 November 2020 and $957 for the exercise of 31,900 listed options exercisable at 3 cents and expiring on 28 April 2023.

Read the announcement.

Related Articles

2023 AGM Resolution Overview

Video Transcript: Robert Proulx, Imagion Biosystems’ President & CEO: [00:00:00] On April 24th, we sent out the notice of meeting for our annual general meeting

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.